Item 7.01. Regulation FD Disclosure.

In order to facilitate discussions with investors at an upcoming conference, Aspira Women's Health Inc. is reporting that 3,849 OVA1 plus tests were performed in the three month period ending December 31, 2020, representing a 7% increase compared to the three month period ending September 30, 2020. Ordering physicians were 2,615 for the three month period ending December 31, 2020, a 7% increase compared to the three month period ending September 30, 2020.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses